chr9-96252977-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000197.2(HSD17B3):c.278-67G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.242 in 941,622 control chromosomes in the GnomAD database, including 29,845 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.26   (  5221   hom.,  cov: 31) 
 Exomes 𝑓:  0.24   (  24624   hom.  ) 
Consequence
 HSD17B3
NM_000197.2 intron
NM_000197.2 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.233  
Publications
3 publications found 
Genes affected
 HSD17B3  (HGNC:5212):  (hydroxysteroid 17-beta dehydrogenase 3) This isoform of 17 beta-hydroxysteroid dehydrogenase is expressed predominantly in the testis and catalyzes the conversion of androstenedione to testosterone.  It preferentially uses NADP as cofactor.  Deficiency can result in male pseudohermaphroditism with gynecomastia. [provided by RefSeq, Jul 2008] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79). 
BP6
Variant 9-96252977-C-T is Benign according to our data. Variant chr9-96252977-C-T is described in ClinVar as Benign. ClinVar VariationId is 1255201.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.292  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| HSD17B3 | ENST00000375263.8  | c.278-67G>A | intron_variant | Intron 3 of 10 | 1 | NM_000197.2 | ENSP00000364412.3 | |||
| ENSG00000285269 | ENST00000643789.1  | n.*1954-67G>A | intron_variant | Intron 14 of 21 | ENSP00000494818.1 | 
Frequencies
GnomAD3 genomes   AF:  0.256  AC: 38781AN: 151666Hom.:  5217  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
38781
AN: 
151666
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.239  AC: 188974AN: 789838Hom.:  24624   AF XY:  0.235  AC XY: 98723AN XY: 419552 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
188974
AN: 
789838
Hom.: 
 AF XY: 
AC XY: 
98723
AN XY: 
419552
show subpopulations 
African (AFR) 
 AF: 
AC: 
6243
AN: 
20740
American (AMR) 
 AF: 
AC: 
5662
AN: 
43878
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
6148
AN: 
21994
East Asian (EAS) 
 AF: 
AC: 
791
AN: 
36680
South Asian (SAS) 
 AF: 
AC: 
10365
AN: 
72840
European-Finnish (FIN) 
 AF: 
AC: 
13560
AN: 
51004
Middle Eastern (MID) 
 AF: 
AC: 
1550
AN: 
4466
European-Non Finnish (NFE) 
 AF: 
AC: 
135244
AN: 
499948
Other (OTH) 
 AF: 
AC: 
9411
AN: 
38288
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.505 
Heterozygous variant carriers
 0 
 7828 
 15655 
 23483 
 31310 
 39138 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 2338 
 4676 
 7014 
 9352 
 11690 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.256  AC: 38813AN: 151784Hom.:  5221  Cov.: 31 AF XY:  0.249  AC XY: 18492AN XY: 74148 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
38813
AN: 
151784
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
18492
AN XY: 
74148
show subpopulations 
African (AFR) 
 AF: 
AC: 
12267
AN: 
41332
American (AMR) 
 AF: 
AC: 
2971
AN: 
15250
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
947
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
141
AN: 
5162
South Asian (SAS) 
 AF: 
AC: 
628
AN: 
4800
European-Finnish (FIN) 
 AF: 
AC: 
2868
AN: 
10518
Middle Eastern (MID) 
 AF: 
AC: 
89
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
18106
AN: 
67944
Other (OTH) 
 AF: 
AC: 
516
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.506 
Heterozygous variant carriers
 0 
 1456 
 2911 
 4367 
 5822 
 7278 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 390 
 780 
 1170 
 1560 
 1950 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
351
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 08, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.